## Mechanism: 
- bDMARD: 
	- binds to soluble and membrane-bound IL6 receptors âž” inhibiting IL6- mediated signaling 
## Indications: 
- rheumatoid arthritis, giant cell arteritis (GCA), active systemic JIA in patients >2 years old. 
## Adverse Effects: 
- upper respiratory tract infections, headache, hypertension, and elevated liver enzymes